<?xml version='1.0' encoding='utf8'?><data><item><title>Perché le ciglia sono così importanti per la salute degli occhi?</title><link>https://notizieinunclick.com/perche-le-ciglia-sono-cosi-importanti-per-la-salute-degli-occhi/</link><ns0keywords>ciglia,può,salute degli occhi,forti e sane,caduta,possono,mantenerle forti,clinica baviera,crescita,fase,spiega i principali,oculare</ns0keywords><pubDate>Thu, 30 Mar 2023 19:11:00 +0200</pubDate><guid isPermaLink="false">notizieinunclick-2f1c722a0ff605b759cc30db38eb8ad8</guid><source country="IT" url="https://www.notizieinunclick.com/feed/">notizieinunclick</source><ns1language>it</ns1language><category>Ricin</category><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>Herpes</category><category>ArtificialTissuesAdverseEffects</category><ns0entity id="3013296" name="Federico Fiorini">Federico Fiorini</ns0entity><georss>44.49381 11.33875</georss></item><item><title>“Dati a lungo termine del vaccino anti-HZ confortanti”. Intervista a Pallavicini</title><link>https://www.dailyhealthindustry.it/dati-a-lungo-termine-del-vaccino-anti-hz-confortanti-intervista-a-pallavicini-ID26253.html</link><ns0keywords>vaccino anti-hz confortanti,dati,termine del vaccino,confcommercio dobbiamo cercare,l'herpes zoster possa,intervista a pallavicini,commenta luca pallavicini,vaccino ricombinante,sanità e cura,studio di estensione,presidente,risultati intermedi,formazione,strutture,intermedi dello studio</ns0keywords><pubDate>Thu, 30 Mar 2023 18:16:00 +0200</pubDate><guid isPermaLink="false">dailyhealthindustry-d0306133fec9baddf7984c51258f1b01</guid><source country="IT" url="http://www.dailyhealthindustry.it/digital-health">dailyhealthindustry</source><ns1language>it</ns1language><category ns0trigger="Zoster[1]; Herpes Zoster[1]; ">HerpesZoster</category><category>Herpes</category><ns0entity id="2799920" name="Luca Pallavicini">Luca Pallavicini</ns0entity><ns0entity id="756512" name="Confcommercio">Confcommercio</ns0entity><georss>45.00000 8.00000</georss></item><item><title>Vaccinazioni anti herpes zoster e anti pneumococco: per chi sono gratuite e come prenotare a Como</title><link>https://www.quicomo.it/attualita/vaccinazioni-anti-herpes-zoster-anti-pneumococco-chi-gratis-come-prenotare-a-como.html</link><ns0keywords>anti herpes zoster,vaccinazione anti pneumococco,prenotare a como,sistema sanitario regionale,regionale nei centri,vaccinazione anti herpes,zoster e anti,vaccinazioni anti herpes,dose,numero verde,seconda</ns0keywords><pubDate>Thu, 30 Mar 2023 17:57:00 +0200</pubDate><guid isPermaLink="false">quicomo-3875ce818d0acf0c5cc24497804a4b4d</guid><source country="IT" url="https://www.quicomo.it/rss">quicomo</source><ns1language>it</ns1language><category>VZV</category><category>PneumococcalInfection</category><category ns0trigger="zoster[2]; herpes zoster[1]; Zoster[9]; Herpes Zoster[9]; ">HerpesZoster</category><category>Herpes</category><georss>44.47867 11.63812</georss></item><item><title>How to build a wooden house: what are the advantages and disadvantages of a wooden house?</title><link>https://www.yourtopia.fr/en/how-to-build-a-wooden-house-what-are-the-advantages-and-disadvantages-of-a-wooden-house/</link><ns0keywords>wooden house,home,building a wooden,time,brick or stone,build a wooden,types,advantages and disadvantages,due,require,pros and cons,materials</ns0keywords><pubDate>Thu, 30 Mar 2023 17:39:00 +0200</pubDate><guid isPermaLink="false">yourtopia-54203696b7cb49d4e210d5ab71f12e76</guid><source country="FR" url="https://yourtopia.fr/">yourtopia</source><ns1language>en</ns1language><category>VZV</category><category ns0trigger="shingles[2]; ">HerpesZoster</category></item><item><title>Vaccinazione anti Herpes Zoster e anti - pneumococco gratuite nei centri delle Asst per over 65 e pazienti fragili</title><link>https://www.virgilio.it/italia/como/notizielocali/vaccinazione_anti_herpes_zoster_e_anti_pneumococco_gratuite_nei_centri_delle_asst_per_over_65_e_pazienti_fragili-70848390.html</link><ns0keywords>vaccinazione anti herpes,pazienti fragili,asst per over,centri delle asst,gratuite nei centri,zoster e anti</ns0keywords><pubDate>Thu, 30 Mar 2023 17:10:00 +0200</pubDate><guid isPermaLink="false">virgilio-5b8cab43cf4a8c8140e34074190b25f1</guid><source country="IT" url="https://www.virgilio.it/italia/ispra/notizielocali/tecnologia">virgilio</source><ns1language>it</ns1language><category ns0trigger="Zoster[2]; Herpes Zoster[2]; ">HerpesZoster</category><category>VZV</category><category>Herpes</category><category>PneumococcalInfection</category></item><item><title>VIDEO: Zoster u petak svira nove pesme na koncertu na Novosadskom sajmu</title><link>https://www.021.rs/story/Novi-Sad/Vodic/336289/VIDEO-Zoster-u-petak-svira-nove-pesme-na-koncertu-na-Novosadskom-sajmu.html</link><ns0keywords>petak svira nove,zoster u petak,video,pesme na koncertu,kuda idu svi,u petak svira,čovjek zvani činjenica,svira nove pesme,novi sad kako,svi ti ljudi,predstavili novi album,nove pesme na,na novosadskom sajmu,na koncertu na</ns0keywords><pubDate>Thu, 30 Mar 2023 16:40:00 +0200</pubDate><guid isPermaLink="false">021-rs-a9c9ac9abd249df9a9efd24ba40484d9</guid><source country="RS" url="https://www.021.rs/">021-rs</source><ns1language>sr</ns1language><category ns0trigger="Zoster[2]; ">HerpesZoster</category><ns0entity id="2670486" name="Mario Knezović">Mario Knezović</ns0entity><georss>45.25167 19.83694</georss></item><item><title>Vaccinazione anti Herpes Zoster e anti-pneumococco gratuite nei centri delle Asst per over 65 e pazienti fragili</title><link>https://www.espansionetv.it/2023/03/30/vaccinazione-anti-herpes-zoster-e-anti-pneumococco-gratuite-nei-centri-delle-asst-per-over-65-e-pazienti-fragili/</link><ns0keywords>pazienti fragili,gratuite nei centri,anti herpes zoster,asst per over,zoster e anti-pneumococco,vaccinazione anti herpes,vaccinali delle asst,over 65,l'herpes zoster,l'asst lariana invita,storia di herpes,patologia cardiovascolare severa,centri delle asst</ns0keywords><pubDate>Thu, 30 Mar 2023 16:39:00 +0200</pubDate><guid isPermaLink="false">espansionetv-d2142af9bea7c38e62392608fd05701a</guid><source country="IT" url="https://www.espansionetv.it/">espansionetv</source><ns1language>it</ns1language><category>VZV</category><category>PneumococcalInfection</category><category ns0trigger="zoster[1]; Zoster[5]; Herpes Zoster[5]; ">HerpesZoster</category><category>Herpes</category></item><item><title>Aperte le prenotazioni per la vaccinazione anti-Herpes Zoster e anti-pneumococco</title><link>https://primacomo.it/attualita/aperte-le-prenotazioni-per-la-vaccinazione-anti-herpes-zoster-e-anti-pneumococco/</link><ns0keywords>anti herpes zoster,vaccinazione anti pneumococco,vaccinazione anti-herpes zoster,zoster e anti-pneumococco,sistema sanitario regionale,aperte le prenotazioni,regionale nei centri,vaccinazione anti herpes,dose,vaccinali delle asst,numero verde,patologia cardiovascolare severa,bpco e asma</ns0keywords><pubDate>Thu, 30 Mar 2023 16:26:00 +0200</pubDate><guid isPermaLink="false">giornaledicomo-00f591d8bf23ce7d2cb80026181d1a11</guid><source country="IT" url="https://primacomo.it">giornaledicomo</source><ns1language>it</ns1language><category>VZV</category><category>PneumococcalInfection</category><category ns0trigger="zoster[1]; Zoster[10]; Herpes Zoster[9]; ">HerpesZoster</category><category>Herpes</category></item><item><title>Vaccinazione anti Herpes Zoster e anti pneumococco: dove, quando e perché farla</title><link>https://www.ciaocomo.it/2023/03/30/vaccinazione-anti-herpes-zoster-e-anti-pneumococco-dove-quando-e-perche-farla/251647/</link><ns0keywords>anti herpes zoster,vaccinazione anti pneumococco,lunedì al venerdì,vaccinazione anti herpes,seconda dose,zoster e anti,patologia cardiovascolare severa,numero verde,nati nel 1958,bpco e asma,2023 i nati,farla,attraverso il portale</ns0keywords><pubDate>Thu, 30 Mar 2023 15:46:00 +0200</pubDate><guid isPermaLink="false">ciaocomo-c41b80242767f07b98c34eb8eac9aaaa</guid><source country="IT" url="https://www.ciaocomo.it/feed/">ciaocomo</source><ns1language>it</ns1language><category>VZV</category><category>PneumococcalInfection</category><category ns0trigger="zoster[1]; Zoster[8]; Herpes Zoster[8]; ">HerpesZoster</category><category>Herpes</category><georss>44.47867 11.63812</georss></item><item><title>Study finds recent shingles infection increases the risk of myocardial infarction</title><link>https://www.news-medical.net/news/20230330/Study-finds-recent-shingles-infection-increases-the-risk-of-myocardial-infarction.aspx</link><ns0keywords>herpes zoster,study finds recent,myocardial infarction risk,odds,mi,shingles infection increases,patients,increased,risk of myocardial,date,recent shingles infection,controls</ns0keywords><pubDate>Thu, 30 Mar 2023 15:42:00 +0200</pubDate><guid isPermaLink="false">newsmedical-2f70822eee3be94b452af58df1b7d041</guid><source country="US" url="https://www.news-medical.net/syndication.axd">newsmedical</source><ns1language>en</ns1language><category>VZV</category><category ns0trigger="zoster[13]; Herpes zoster[1]; herpes zoster[7]; Zoster[2]; shingles[3]; Herpes Zoster[1]; Shingles[1]; ">HerpesZoster</category><category>Herpes</category><ns0entity id="3188790" name="Image Credit">Image Credit</ns0entity><ns0entity id="2107753" name="US Department">US Department</ns0entity><georss>38.89511 -77.03637</georss></item><item><title>Open day vaccinali per tutto il mese di aprile: anti Herpes Zoster, anti Pneumococco e anti Papilloma virus</title><link>https://www.varesenoi.it/2023/03/30/leggi-notizia/argomenti/salute-3/articolo/open-day-vaccinali-per-tutto-il-mese-di-marzo-anti-herpes-zoster-anti-pneumococco-e-anti-papilloma.html</link><ns0keywords>anti herpes zoster,open day vaccinali,anti papilloma virus,circolo di varese,terra della portineria,mese di aprile,anti pneumococco,viale borri,asst sette laghi,vaccinazioni,pneumococco e anti,dell'ospedale di circolo</ns0keywords><pubDate>Thu, 30 Mar 2023 15:27:00 +0200</pubDate><guid isPermaLink="false">varesenoi-092b1c6a5d8fbcc6fd477e7af603b6fb</guid><source country="IT" url="http://www.varesenoi.it/links/rss/argomenti/territorio/rss.xml">varesenoi</source><ns1language>it</ns1language><category>VZV</category><category>PneumococcalInfection</category><category ns0trigger="fuoco di Sant'Antonio[1]; Zoster[2]; Herpes Zoster[2]; ">HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><ns0entity id="2931927" name="Ospedale di Circolo">Ospedale di Circolo</ns0entity><ns0entity id="2058260" name="Sette Laghi">Sette Laghi</ns0entity><georss>45.82058 8.82511</georss></item><item><title>Open day vaccinali per tutto il mese di aprile: anti Herpes Zoster, anti Pneumococco e anti Papilloma virus</title><link>https://www.informazioneonline.it/2023/03/30/leggi-notizia/argomenti/salute-4/articolo/open-day-vaccinali-per-tutto-il-mese-di-marzo-anti-herpes-zoster-anti-pneumococco-e-anti-papilloma.html</link><ns0keywords>anti herpes zoster,open day vaccinali,anti papilloma virus,circolo di varese,terra della portineria,mese di aprile,anti pneumococco,viale borri,asst sette laghi,vaccinazioni,pneumococco e anti,dell'ospedale di circolo</ns0keywords><pubDate>Thu, 30 Mar 2023 15:18:00 +0200</pubDate><guid isPermaLink="false">informazioneonline-092b1c6a5d8fbcc6fd477e7af603b6fb</guid><source country="IT" url="https://www.informazioneonline.it/">informazioneonline</source><ns1language>it</ns1language><category>VZV</category><category>PneumococcalInfection</category><category ns0trigger="fuoco di Sant'Antonio[1]; Zoster[2]; Herpes Zoster[2]; ">HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><ns0entity id="2931927" name="Ospedale di Circolo">Ospedale di Circolo</ns0entity><ns0entity id="2058260" name="Sette Laghi">Sette Laghi</ns0entity><georss>45.82058 8.82511</georss></item><item><title>Open day vaccinali per tutto il mese di aprile a Varese: anti Herpes Zoster, anti Pneumococco e anti Papilloma virus</title><link>https://agenparl.eu/2023/03/30/open-day-vaccinali-per-tutto-il-mese-di-aprile-a-varese-anti-herpes-zoster-anti-pneumococco-e-anti-papilloma-virus/</link><ns0keywords>open day vaccinali,anti herpes zoster,mese di aprile,anti papilloma virus,pneumococco e anti,invio in allegato,sede vaccinale dell'ospedale,aprile a varese,fuoco di sant'antonio,partecipare agli open,dettagli per partecipare,dell'ospedale di circolo,anti pneumococco,allegato le locandine</ns0keywords><pubDate>Thu, 30 Mar 2023 15:13:00 +0200</pubDate><guid isPermaLink="false">agenparl-26fa94270655d2b419392b3c1102db73</guid><source country="IT" url="https://agenparl.eu/category/reg/feed/">agenparl</source><ns1language>it</ns1language><category>VZV</category><category>PneumococcalInfection</category><category ns0trigger="Zoster[2]; Herpes Zoster[2]; fuoco di Sant’Antonio[1]; ">HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><ns0entity id="2931927" name="Ospedale di Circolo">Ospedale di Circolo</ns0entity><ns0entity id="2058260" name="Sette Laghi">Sette Laghi</ns0entity><ns0entity id="2743700" name="Francesca Mauri">Francesca Mauri</ns0entity><georss>45.82058 8.82511</georss></item><item><title>Acasti Pharma Inc. Announces the Resignation of a Director</title><link>https://www.prnewswire.com/news-releases/acasti-pharma-inc-announces-the-resignation-of-a-director-301785452.html</link><ns0keywords>specialty pharma company,orphan diseases,forward-looking statements,acasti pharma,announces the resignation,board of directors,drug,director,qc march 30,press release,securities,2023 /prnewswire/ acasti,candidates addressing rare</ns0keywords><pubDate>Thu, 30 Mar 2023 14:34:00 +0200</pubDate><guid isPermaLink="false">prnewswire-dc4a36aaed4abc0a32c7b0d06e9e72bd</guid><source country="US" url="http://www.prnewswire.com/rss/all-news-releases-from-PR-newswire-news.rss">prnewswire</source><ns1language>en</ns1language><category ns0trigger="zoster[1]; shingles[1]; ">HerpesZoster</category><category>VZV</category><ns0entity id="89236" name="Nasdaq Composite">NASDAQ</ns0entity><ns0entity id="89236" name="Nasdaq Composite">The NASDAQ</ns0entity><ns0entity id="2316396" name="Acasti Pharma Inc">Acasti Pharma Inc</ns0entity><georss>38.89511 -77.03637</georss></item><item><title>Acasti Pharma Inc. Announces the Resignation of a Director</title><link>https://www.streetinsider.com/PRNewswire/Acasti+Pharma+Inc.+Announces+the+Resignation+of+a+Director/21439977.html</link><ns0keywords>drug delivery technologies,forward-looking statements,announces the resignation,press release,acasti pharma,securities exchange act,orphan diseases,lead clinical assets,orphan drug designation,company's board,litigation reform act,board of directors,director,future endeavors</ns0keywords><pubDate>Thu, 30 Mar 2023 14:34:00 +0200</pubDate><guid isPermaLink="false">streetinsider-b73bf41e0f7047f0ecd32e328e97bb18</guid><source country="US" url="https://www.streetinsider.com/Press+Releases">streetinsider</source><ns1language>en</ns1language><category ns0trigger="zoster[1]; shingles[1]; ">HerpesZoster</category><category>VZV</category><ns0entity id="89236" name="Nasdaq Composite">NASDAQ</ns0entity><ns0entity id="89236" name="Nasdaq Composite">The NASDAQ</ns0entity><ns0entity id="2316396" name="Acasti Pharma Inc">Acasti Pharma Inc</ns0entity><georss>35.91282 -100.38208</georss></item><item><title>Acasti Pharma Inc. Announces the Resignation of a Director</title><link>https://www.marketscreener.com/quote/stock/ACASTI-PHARMA-INC-24446197/news/Acasti-Pharma-Inc-Announces-the-Resignation-of-a-Director-43382444/</link><ns0keywords>specialty pharma company,orphan diseases,forward-looking statements,acasti pharma,announces the resignation,board of directors,drug,director,qc march 30,press release,securities,2023 /prnewswire/ acasti,candidates addressing rare</ns0keywords><pubDate>Thu, 30 Mar 2023 14:31:00 +0200</pubDate><guid isPermaLink="false">4-traders-9f772d44355cc2324cac2f25bc9137d8</guid><source country="FR" url="https://www.marketscreener.com/rss/FeedNews.php">4-traders</source><ns1language>en</ns1language><category ns0trigger="zoster[1]; shingles[1]; ">HerpesZoster</category><category>VZV</category><ns0entity id="89236" name="Nasdaq Composite">NASDAQ</ns0entity><ns0entity id="89236" name="Nasdaq Composite">The NASDAQ</ns0entity><ns0entity id="2316396" name="Acasti Pharma Inc">Acasti Pharma Inc</ns0entity><georss>38.89511 -77.03637</georss></item><item><title>aumento de casos de culebrilla, ¿quién debe vacunarse?</title><link>https://www.notiulti.com/aumento-de-casos-de-culebrilla-quien-debe-vacunarse/</link><ns0keywords>virus,varicela zoster afecta,años,herpes,casos de culebrilla,aumento de casos,personas,afecta los nervios,vacuna,nervios periféricos,infección viral causado</ns0keywords><pubDate>Thu, 30 Mar 2023 14:14:00 +0200</pubDate><guid isPermaLink="false">notiulti-6ada0cd3cc545434910971aa406d64ac</guid><source country="ES" url="https://www.notiulti.com/feed/">notiulti</source><ns1language>es</ns1language><category>Chickenpox</category><category>VZV</category><category>CoronavirusInfection</category><category ns0trigger="zoster[2]; herpes zoster[1]; Zoster[1]; Herpes Zoster[1]; ">HerpesZoster</category><category>Herpes</category><category>ArtificialTissuesAdverseEffects</category><ns0entity id="1124324" name="Sistema Nacional de Salud">Sistema Nacional de Salud</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><georss>40.41650 -3.70256</georss></item><item><title>Szczepionka na półpasiec jest już dostępna w Polsce. Kto i jak może się zaszczepić?</title><link>https://pomorska.pl/szczepionka-na-polpasiec-jest-juz-dostepna-w-polsce-skorzystaj-aby-uchronic-sie-przed-ta-grozna-choroba-kto-i-jak-moze-sie/ar/c14-17417025</link><ns0keywords>osób,półpaśca,varicella zoster virus,szczepionka na półpasiec,ospy wietrznej,dostępna w polsce,vzv,wirusowa choroba zakaźna,półpasiec to wirusowa,choroby,zaszczepić</ns0keywords><pubDate>Thu, 30 Mar 2023 12:18:00 +0200</pubDate><guid isPermaLink="false">pomorska-fc42600138b7030ff9816c481c09af42</guid><source country="PL" url="https://pomorska.pl/">pomorska</source><ns1language>pl</ns1language><category>VZV</category><category>Chickenpox</category><category ns0trigger="zoster[1]; herpes zoster[1]; półpasiec[7]; Zoster[1]; Półpasiec[3]; ">HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><category>AIDS-HIV</category><ns0entity id="10101" name="EU">UE</ns0entity></item><item><title>Szczepionka na półpasiec jest już dostępna w Polsce. Kto i jak może się zaszczepić?</title><link>https://nowiny24.pl/szczepionka-na-polpasiec-jest-juz-dostepna-w-polsce-skorzystaj-aby-uchronic-sie-przed-ta-grozna-choroba-kto-i-jak-moze-sie/ar/c14-17417025</link><ns0keywords>osób,półpaśca,varicella zoster virus,szczepionka na półpasiec,ospy wietrznej,dostępna w polsce,vzv,wirusowa choroba zakaźna,półpasiec to wirusowa,choroby,zaszczepić</ns0keywords><pubDate>Thu, 30 Mar 2023 12:15:00 +0200</pubDate><guid isPermaLink="false">nowiny24-fc42600138b7030ff9816c481c09af42</guid><source country="PL" url="https://nowiny24.pl/">nowiny24</source><ns1language>pl</ns1language><category>VZV</category><category>Chickenpox</category><category ns0trigger="zoster[1]; herpes zoster[1]; półpasiec[7]; Zoster[1]; Półpasiec[3]; ">HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><category>AIDS-HIV</category><ns0entity id="10101" name="EU">UE</ns0entity></item><item><title>Szczepionka na półpasiec jest już dostępna w Polsce. Skorzystaj, aby uchronić się przed tą groźną chorobą. Kto i jak może się zaszczepić?</title><link>https://dzienniklodzki.pl/szczepionka-na-polpasiec-jest-juz-dostepna-w-polsce-skorzystaj-aby-uchronic-sie-przed-ta-grozna-choroba-kto-i-jak-moze-sie/ar/c14-17417025</link><ns0keywords>osób,półpaśca,ospy wietrznej,szczepionka na półpasiec,varicella zoster virus,dostępna w polsce,vzv,groźną chorobą,skorzystaj,choroby,wirusowa choroba zakaźna</ns0keywords><pubDate>Thu, 30 Mar 2023 12:13:00 +0200</pubDate><guid isPermaLink="false">dzienniklodzki-fc42600138b7030ff9816c481c09af42</guid><source country="PL" url="https://dzienniklodzki.pl/rss/dzienniklodzki.xml">dzienniklodzki</source><ns1language>pl</ns1language><category>VZV</category><category>Chickenpox</category><category ns0trigger="zoster[1]; herpes zoster[1]; półpasiec[7]; Zoster[1]; Półpasiec[3]; ">HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><category>AIDS-HIV</category><ns0entity id="10101" name="EU">UE</ns0entity></item><item><title>Szczepionka na półpasiec jest już dostępna w Polsce. Kto i jak może się zaszczepić?</title><link>https://nowosci.com.pl/szczepionka-na-polpasiec-jest-juz-dostepna-w-polsce-skorzystaj-aby-uchronic-sie-przed-ta-grozna-choroba-kto-i-jak-moze-sie/ar/c14-17417025</link><ns0keywords>osób,półpaśca,varicella zoster virus,szczepionka na półpasiec,ospy wietrznej,dostępna w polsce,vzv,wirusowa choroba zakaźna,półpasiec to wirusowa,choroby,zaszczepić</ns0keywords><pubDate>Thu, 30 Mar 2023 12:10:00 +0200</pubDate><guid isPermaLink="false">nowosci-fc42600138b7030ff9816c481c09af42</guid><source country="PL" url="https://nowosci.com.pl/">nowosci</source><ns1language>pl</ns1language><category>VZV</category><category>Chickenpox</category><category ns0trigger="zoster[1]; herpes zoster[1]; półpasiec[7]; Zoster[1]; Półpasiec[3]; ">HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><category>AIDS-HIV</category><ns0entity id="10101" name="EU">UE</ns0entity></item><item><title>Szczepionka na półpasiec jest już dostępna w Polsce. Skorzystaj, aby uchronić się przed tą groźną chorobą. Kto i jak może się zaszczepić?</title><link>https://gloswielkopolski.pl/szczepionka-na-polpasiec-jest-juz-dostepna-w-polsce-skorzystaj-aby-uchronic-sie-przed-ta-grozna-choroba-kto-i-jak-moze-sie/ar/c14-17417025</link><ns0keywords>osób,półpaśca,ospy wietrznej,szczepionka na półpasiec,varicella zoster virus,dostępna w polsce,vzv,groźną chorobą,skorzystaj,choroby,wirusowa choroba zakaźna</ns0keywords><pubDate>Thu, 30 Mar 2023 12:07:00 +0200</pubDate><guid isPermaLink="false">glos-fc42600138b7030ff9816c481c09af42</guid><source country="PL" url="https://gloswielkopolski.pl/rss/gloswielkopolski.xml">glos</source><ns1language>pl</ns1language><category>VZV</category><category>Chickenpox</category><category ns0trigger="zoster[1]; herpes zoster[1]; półpasiec[7]; Zoster[1]; Półpasiec[3]; ">HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><category>AIDS-HIV</category><ns0entity id="10101" name="EU">UE</ns0entity></item><item><title>Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Arthritis, Rheumatoid, Date of authorisation: 16/12/2019, Revision: 13, Status: Authorised</title><link>https://www.ema.europa.eu/en/medicines/human/EPAR/rinvoq</link><ns0keywords>public assessment report,symptoms,compared,studies,patients taking rinvoq,date of authorisation,rheumatoid arthritis,medicines european public,human medicines european,disease,rinvoq was effective,placebo,european public assessment,assessment report epar</ns0keywords><pubDate>Thu, 30 Mar 2023 10:37:00 +0200</pubDate><guid isPermaLink="false">ema-9ce814efa33c8ea8d3821b8392681d08</guid><source country="GB" url="https://www.ema.europa.eu/en/whats-new.xml">ema</source><ns1language>en</ns1language><category>Influenza</category><category ns0trigger="zoster[1]; herpes zoster[1]; shingles[1]; ">HerpesZoster</category><category>EMA</category><category>BloodProducts</category><category>RespiratorySyndrome</category><category>HerpesSimplexVirus</category><category>VZV</category><category>Herpes</category><category>OfficialEMA</category><category>BloodProductsAdverseEffects</category><category>ArtificialTissuesAdverseEffects</category><ns0entity id="10101" name="EU">EU</ns0entity><ns0entity id="98455" name="Medicines Agency">Medicines Agency</ns0entity><ns0entity id="508152" name="European Medicines Agency">European Medicines Agency</ns0entity></item><item><title>Human medicines European public assessment report (EPAR): Xeljanz, tofacitinib, Arthritis, Rheumatoid, Date of authorisation: 22/03/2017, Date of refusal: 25/04/2013, Revision: 26, Status: Authorised</title><link>https://www.ema.europa.eu/en/medicines/human/EPAR/xeljanz</link><ns0keywords>xeljanz,patients,public assessment report,treatment,date of authorisation,placebo,medicines european public,human medicines european,arthritis,symptoms,european public assessment,study,day,assessment report epar</ns0keywords><pubDate>Thu, 30 Mar 2023 10:37:00 +0200</pubDate><guid isPermaLink="false">ema-4ddf81e00d7c2bbbe2b0b72a3cd188cb</guid><source country="GB" url="https://www.ema.europa.eu/en/whats-new.xml">ema</source><ns1language>en</ns1language><category ns0trigger="zoster[1]; herpes zoster[1]; shingles[1]; ">HerpesZoster</category><category>EMA</category><category>BloodProducts</category><category>VZV</category><category>Herpes</category><category>OfficialEMA</category><category>BloodProductsAdverseEffects</category><ns0entity id="10101" name="EU">EU</ns0entity><ns0entity id="98455" name="Medicines Agency">Medicines Agency</ns0entity><ns0entity id="508152" name="European Medicines Agency">European Medicines Agency</ns0entity><georss>50.50301 13.63617</georss></item><item><title>Herpes zoster: Za večino je pasavec boleča diagnoza 10:54</title><link>https://prvi.rtvslo.si/podkast/ultrazvok/2288722/174946614</link><ns0keywords>pasavec boleča diagnoza,herpes zoster,medicine je obširno,izredno hiter,področje medicine,iztok konc,zdravnik miljen vidaković,večino je pasavec,področij,razvoj pa izredno,oddajo ultrazvok vabimo,zaradi,rahlo zastarele,boleča diagnoza 10:54</ns0keywords><pubDate>Thu, 30 Mar 2023 09:19:00 +0200</pubDate><guid isPermaLink="false">rtvslo-f34041016e71d02fea29ac79526a7082</guid><source country="SI" url="https://www.rtvslo.si/">rtvslo</source><ns1language>sl</ns1language><category ns0trigger="zoster[2]; Herpes zoster[2]; ">HerpesZoster</category><category>VZV</category><category>Herpes</category><georss>45.54694 13.72944</georss></item><item><title>Mercato dei sistemi di somministrazione di farmaci transdermici 2023: crescita potenziale, dimensioni, quota, analisi regionale, previsioni di prospettive competitive entro il 2030</title><link>http://digitalesiciliana.com/2023/03/30/mercato-dei-sistemi-di-somministrazione-di-farmaci-transdermici-2023-crescita-potenziale-dimensioni-quota-analisi-regionale-previsioni-di-prospettive-competitive-entro-il-2030/</link><ns0keywords>somministrazione transdermica,sistemi di somministrazione,mercato dei sistemi,somministrazione di farmaci,rapporto,prospettive competitive entro,farmaci transdermici 2023,disturbi,crescita</ns0keywords><pubDate>Thu, 30 Mar 2023 07:03:00 +0200</pubDate><guid isPermaLink="false">digitalesiciliana-56d5167ce1f0b1cbe8a8c26be672ce35</guid><source country="IT" url="http://digitalesiciliana.com/">digitalesiciliana</source><ns1language>it</ns1language><category>CoronavirusInfection</category><category ns0trigger="zoster[1]; herpes zoster[1]; fuoco di Sant’Antonio[1]; ">HerpesZoster</category><category>Herpes</category><ns0entity id="688250" name="Purdue Pharma">Purdue Pharma</ns0entity><ns0entity id="1655064" name="Lubrizol Corporation">Lubrizol Corporation</ns0entity><ns0entity id="2399452" name="Endo International">Endo International</ns0entity><ns0entity id="12537" name="Novartis">Novartis</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2528522" name="Coronavirus">Covid</ns0entity><georss>40.71612 14.94010</georss></item><item><title>Calls for removal of barriers to pharmacist administered vaccinations in Queensland</title><link>https://www.nationaltribune.com.au/calls-for-removal-of-barriers-to-pharmacist-administered-vaccinations-in-queensland/</link><ns0keywords>pharmacists,services to queenslanders,vaccinations in queensland,psa queensland president,pharmaceutical society,removal of barriers,hon yvette d'ath,queensland government,north queensland scope,pharmacist administered vaccinations,calls for removal,vaccines,barriers to pharmacist,nicole floyd havemet,shane macdonald</ns0keywords><pubDate>Thu, 30 Mar 2023 04:29:00 +0200</pubDate><guid isPermaLink="false">nationaltribune-f6b77222a0031e1963c8263523e781a3</guid><source country="AU" url="https://www.nationaltribune.com.au/">nationaltribune</source><ns1language>en</ns1language><category>Herpes</category><category>HepatitisB</category><category>HPV</category><category>CoronavirusInfection</category><category>vaccination_gen</category><category ns0trigger="Zoster[1]; Herpes Zoster[1]; ">HerpesZoster</category><ns0entity id="2001714" name="PSA">PSA</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="46959" name="Pharmaceutical Society">Pharmaceutical Society</ns0entity><ns0entity id="2176414" name="Shane MacDonald">Shane MacDonald</ns0entity><georss>-20.00000 145.00000</georss></item><item><title>Cochabamba DR. JAVIER VARGAS DE LA FUENTE ¡Adiós al dolor! Aquí, usamos acupuntura y homeopatía para eliminar tu dolor y molestia de raíz. ¡No esperes más para sentirte mejor!</title><link>https://www.boliviaentusmanos.com/amarillas/businesscard/dr-javier-vargas-de-la-fuente.html</link><ns0keywords>javier vargas,medicina convencional,cochabamba dr,¡adiós al dolor,enfermedades autoinmunes,fuente ¡adiós,usamos acupuntura,molestia de raíz,apoyo en adicciones,mejorar,homeopatía para eliminar</ns0keywords><pubDate>Thu, 30 Mar 2023 03:52:00 +0200</pubDate><guid isPermaLink="false">boliviaentusmanos-4f790b04d8072be5d57f62128ebd80aa</guid><source country="BO" url="https://www.boliviaentusmanos.com/">boliviaentusmanos</source><ns1language>es</ns1language><category ns0trigger="zoster[1]; Herpes zoster[1]; ">HerpesZoster</category><category>Herpes</category><ns0entity id="655892" name="Javier Vargas">JAVIER VARGAS</ns0entity><georss>-17.38950 -66.15680</georss></item><item><title>Cochabamba ACUHOMED ¡Adiós al dolor! Aquí, usamos acupuntura y homeopatía para eliminar tu dolor y molestia de raíz. ¡No esperes más para sentirte mejor!</title><link>https://www.boliviaentusmanos.com/amarillas/businesscard/acuhomed.html</link><ns0keywords>homeopatía para eliminar,molestia de raíz,medicina convencional,¡adiós al dolor,enfermedades autoinmunes,cochabamba acuhomed ¡adiós,usamos acupuntura,apoyo en adicciones,mejorar,eliminar tu dolor,dolor y molestia</ns0keywords><pubDate>Thu, 30 Mar 2023 01:07:00 +0200</pubDate><guid isPermaLink="false">boliviaentusmanos-f1a647864377a5ab6daa3572561bc392</guid><source country="BO" url="https://www.boliviaentusmanos.com/">boliviaentusmanos</source><ns1language>es</ns1language><category ns0trigger="zoster[1]; Herpes zoster[1]; ">HerpesZoster</category><category>Herpes</category><georss>-17.38950 -66.15680</georss></item><item><title>Quota di mercato e tendenze globali di Ash3 2023-2029</title><link>http://digitalesiciliana.com/2023/03/30/quota-di-mercato-e-tendenze-globali-di-ash3-2023-2029/</link><ns0keywords>rapporto,market,the future,quota di mercato,tendenze globali,global,ottieni un pdf,mercato e tendenze,pdf di esempio,mercato ash3 fornisce,un'analisi,globali di ash3,software</ns0keywords><pubDate>Wed, 29 Mar 2023 23:52:00 +0200</pubDate><guid isPermaLink="false">digitalesiciliana-ee52b6d8552acf4d8adb1b82f072fc8c</guid><source country="IT" url="http://digitalesiciliana.com/">digitalesiciliana</source><ns1language>it</ns1language><category>Herpes</category><category>Communicabledisease</category><category>EnvironmentalRestoration</category><category ns0trigger="Zoster[1]; Herpes Zoster[1]; ">HerpesZoster</category><category>Arsine</category><category>CoronavirusInfection</category><ns0entity id="2152771" name="Pet Products">Pet Products</ns0entity><ns0entity id="2623757" name="Warehouse Management">Warehouse Management</ns0entity><ns0entity id="2239365" name="Messer Group">Messer Group</ns0entity><ns0entity id="2551695" name="Machine Market">Machine Market</ns0entity><ns0entity id="2575084" name="Treatment Market">Treatment Market</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2286412" name="Ram Air">Ram Air</ns0entity><ns0entity id="2260141" name="Talent Management">Talent Management</ns0entity><ns0entity id="84785" name="Air Liquide">Air Liquide</ns0entity><ns0entity id="932669" name="Tailor Made">Tailor Made</ns0entity><ns0entity id="2520178" name="Packaging Market">Packaging Market</ns0entity><ns0entity id="3304100" name="Hunter Syndrome">Hunter Syndrome</ns0entity><ns0entity id="458864" name="Sumitomo Metal Mining">Sumitomo</ns0entity><ns0entity id="2599455" name="Lighting Market">Lighting Market</ns0entity><ns0entity id="2525755" name="POS Software">POS Software</ns0entity><ns0entity id="2559001" name="Air Products and Chemicals">Air Products and Chemicals</ns0entity><georss>39.90750 116.39723</georss></item><item><title>FDA Converts to Full Approval Indication for KEYTRUDA® for Certain Adult and Pediatric Patients With Advanced Microsatellite Instability-High or Mismatch Repair Deficient Solid Tumors</title><link>https://investingnews.com/fda-converts-to-full-approval-indication-for-keytruda-r-for-certain-adult-and-pediatric-patients-with-advanced-microsatellite-instability-high-or-mismatch-repair-deficient-solid-tumors/</link><ns0keywords>patients receiving keytruda,pediatric patients,adverse reactions,patients with advanced,lenvima,keytruda was discontinued,tumors,treatment of patients,grade,disease progression,discontinuation of keytruda,occurred</ns0keywords><pubDate>Wed, 29 Mar 2023 23:00:00 +0200</pubDate><guid isPermaLink="false">investingnews-a1f4329bef2332e53b3eeac9ddf95841</guid><source country="CA" url="https://investingnews.com/category/daily/life-science-investing/feed/">investingnews</source><ns1language>en</ns1language><category>Pneumonia</category><category>Herpes</category><category>GastroentericSyndrome</category><category>Encephalitis</category><category>BloodProducts</category><category ns0trigger="zoster[2]; herpes zoster[2]; ">HerpesZoster</category><category>HaemorrhagicSyndrome</category><category>VZV</category><category>RespiratorySyndrome</category><category>Cytomegalovirus</category><category>BloodProductsAdverseEffects</category><ns0entity id="2939849" name="Breast Cancer">Breast Cancer</ns0entity><ns0entity id="3027720" name="Moores Cancer Center">Moores Cancer Center</ns0entity><ns0entity id="251307" name="Eliav Barr">Eliav Barr</ns0entity><ns0entity id="70670" name="Annual Meeting">Annual Meeting</ns0entity><ns0entity id="3003426" name="University of California San Diego">University of California San Diego</ns0entity><ns0entity id="2589079" name="Access Program">Access Program</ns0entity><ns0entity id="2254033" name="IIB">IIB</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="825531" name="Eisai Co">Eisai</ns0entity><ns0entity id="2013862" name="Nervous System">Nervous System</ns0entity><ns0entity id="2408413" name="Research Laboratories">Research Laboratories</ns0entity><ns0entity id="2250587" name="Cancer Institute">Cancer Institute</ns0entity><ns0entity id="2246399" name="Development Agreement">Development Agreement</ns0entity><ns0entity id="839570" name="New England Journal of Medicine">New England Journal of Medicine</ns0entity></item><item><title>Shingles: Contagion, Symptoms and Treatment | &gt; – Guide</title><link>https://www.breakinglatest.news/health/shingles-contagion-symptoms-and-treatment-guide/</link><ns0keywords>contagion,people,vaccination,chickenpox infection,symptoms and treatment,pain,symptoms of shingles,guide,post-herpetic neuralgia,03/24/2023 4:55 p.m,long</ns0keywords><pubDate>Wed, 29 Mar 2023 22:47:00 +0200</pubDate><guid isPermaLink="false">breakinglatest-9435594dbfbaaf25279e4032408ad94a</guid><source country="US" url="https://www.breakinglatest.news/category/health/">breakinglatest</source><ns1language>en</ns1language><category>Herpes</category><category>Antiviral</category><category ns0trigger="zoster[2]; herpes zoster[1]; shingles[19]; Shingles[3]; ">HerpesZoster</category><category>Chickenpox</category><category>VZV</category><category>ArtificialTissuesAdverseEffects</category><ns0entity id="3113434" name="Ramsay Hunt">Ramsay Hunt</ns0entity><ns0entity id="1229724" name="Justin Bieber">Justin Bieber</ns0entity><georss>52.52437 13.41053</georss></item><item><title>FDA Converts to Full Approval Indication for KEYTRUDA® (pembrolizumab) for Certain Adult and Pediatric Patients With Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Solid Tumors</title><link>https://www.eagletribune.com/region/fda-converts-to-full-approval-indication-for-keytruda-pembrolizumab-for-certain-adult-and-pediatric-patients/article_31122ba1-0085-53f3-a13f-952fd9fc35a4.html</link><ns0keywords>adverse reactions,treatment,patients receiving keytruda,grade,pediatric patients,keytruda was discontinued,withheld reinitiated keytruda,indication,discontinuation of keytruda,patients with advanced,cancer,adult and pediatric,fda converts</ns0keywords><pubDate>Wed, 29 Mar 2023 22:37:00 +0200</pubDate><guid isPermaLink="false">eagletribune-2ecb2457648b362b418a3fed8945b265</guid><source country="US" url="http://www.eagletribune.com/search/?f=rss&amp;t=article&amp;c=&amp;l=50&amp;s=start_time&amp;sd=desc">eagletribune</source><ns1language>en</ns1language><category>Pneumonia</category><category>Measles</category><category>Herpes</category><category>GastroentericSyndrome</category><category>Encephalitis</category><category>BloodProducts</category><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>RespiratorySyndrome</category><category>Cytomegalovirus</category><category>BloodProductsAdverseEffects</category><ns0entity id="2589079" name="Access Program">Access Program</ns0entity><ns0entity id="2241552" name="Scot Ebbinghaus">Scot Ebbinghaus</ns0entity><ns0entity id="2254033" name="IIB">IIB</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="2939849" name="Breast Cancer">Breast Cancer</ns0entity><ns0entity id="2013862" name="Nervous System">Nervous System</ns0entity><ns0entity id="2408413" name="Research Laboratories">Research Laboratories</ns0entity></item><item><title>FDA Converts to Full Approval Indication for KEYTRUDA (pembrolizumab) for Certain Adult and Pediatric Patients With Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Solid Tumors</title><link>https://www.wallstreet-online.de/nachricht/16744158-fda-converts-to-full-approval-indication-for-keytruda-pembrolizumab-for-certain-adult-and-pediatric-patients-with-advanced-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr-solid-tumors</link><ns0keywords>patients receiving keytruda,adverse reactions,pediatric patients,grade,keytruda was discontinued,approval,withheld reinitiated keytruda,indication,patients with advanced,discontinuation of keytruda,treatment,keytruda pembrolizumab,cancer</ns0keywords><pubDate>Wed, 29 Mar 2023 22:30:00 +0200</pubDate><guid isPermaLink="false">wallstreet-online-62ba08b49a9fb9ea027150e52ed6690f</guid><source country="DE" url="https://www.wallstreet-online.de/rss/nachrichten-weitere-nachrichten.xml">wallstreet-online</source><ns1language>en</ns1language><category>Pneumonia</category><category>Measles</category><category>Herpes</category><category>GastroentericSyndrome</category><category>Encephalitis</category><category>BloodProducts</category><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>RespiratorySyndrome</category><category>Cytomegalovirus</category><category>BloodProductsAdverseEffects</category><ns0entity id="2589079" name="Access Program">Access Program</ns0entity><ns0entity id="2254033" name="IIB">IIB</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="2939849" name="Breast Cancer">Breast Cancer</ns0entity><ns0entity id="2013862" name="Nervous System">Nervous System</ns0entity></item><item><title>FDA Converts to Full Approval Indication for KEYTRUDA® (pembrolizumab) for Certain Adult and Pediatric Patients With Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Solid Tumors</title><link>https://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/FDA-Converts-to-Full-Approval-Indication-for-KEYTRUDA-pembrolizumab-for-Certain-Adult-and-Pediatr-43373275/</link><ns0keywords>patients receiving keytruda,pediatric patients,adverse reactions,grade,keytruda was discontinued,approval,withheld reinitiated keytruda,indication,patients with advanced,discontinuation of keytruda,treatment,adult and pediatric,cancer</ns0keywords><pubDate>Wed, 29 Mar 2023 22:19:00 +0200</pubDate><guid isPermaLink="false">4-traders-b5159ece33f76a32ced66de848e7f899</guid><source country="FR" url="https://www.marketscreener.com/rss/FeedNews.php">4-traders</source><ns1language>en</ns1language><category>Pneumonia</category><category>Measles</category><category>Herpes</category><category>GastroentericSyndrome</category><category>Encephalitis</category><category>BloodProducts</category><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>RespiratorySyndrome</category><category>Cytomegalovirus</category><category>BloodProductsAdverseEffects</category><ns0entity id="2589079" name="Access Program">Access Program</ns0entity><ns0entity id="2254033" name="IIB">IIB</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="2939849" name="Breast Cancer">Breast Cancer</ns0entity><ns0entity id="2013862" name="Nervous System">Nervous System</ns0entity></item><item><title>FDA Converts to Full Approval Indication for KEYTRUDAÂ® (pembrolizumab) for Certain Adult and Pediatric Patients With Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMM</title><link>https://www.streetinsider.com/Business+Wire/FDA+Converts+to+Full+Approval+Indication+for+KEYTRUDA%C2%AE+(pembrolizumab)+for+Certain+Adult+and+Pediatric+Patients+With+Advanced+Microsatellite+Instability-High+(MSI-H)+or+Mismatch+Repair+Deficient+(dMM/21436469.html</link><ns0keywords>patients receiving keytruda,pediatric patients,adverse reactions,keytruda was discontinued,treatment,approval,indication,cancer,patients with advanced,fda converts,keytrudaâ® pembrolizumab,grade,discontinuation of keytruda</ns0keywords><pubDate>Wed, 29 Mar 2023 22:18:00 +0200</pubDate><guid isPermaLink="false">streetinsider-6d7777b84f02f66c9f5aaa21d9751676</guid><source country="US" url="https://www.streetinsider.com/Press+Releases">streetinsider</source><ns1language>en</ns1language><category>Pneumonia</category><category>Measles</category><category>Herpes</category><category>GastroentericSyndrome</category><category>Encephalitis</category><category>BloodProducts</category><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>RespiratorySyndrome</category><category>Cytomegalovirus</category><category>BloodProductsAdverseEffects</category><ns0entity id="2589079" name="Access Program">Access Program</ns0entity><ns0entity id="2254033" name="IIB">IIB</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="2939849" name="Breast Cancer">Breast Cancer</ns0entity><ns0entity id="2013862" name="Nervous System">Nervous System</ns0entity></item><item><title>Merck (MRK) Announces FDA Converts to Full Approval Indication for KEYTRUDA for MSI-H</title><link>https://www.streetinsider.com/Corporate+News/Merck+%28MRK%29+Announces+FDA+Converts+to+Full+Approval+Indication+for+KEYTRUDA+for+MSI-H/21436509.html</link><ns0keywords>treatment,patients receiving keytruda,merck,announces fda converts,immune-mediated adverse reactions,grade,withheld reinitiated keytruda,keytruda was discontinued,including,pneumonitis,discontinuation of keytruda,cancer</ns0keywords><pubDate>Wed, 29 Mar 2023 22:18:00 +0200</pubDate><guid isPermaLink="false">streetinsider-988bf714476276ed6bf1e0a7dfe235f0</guid><source country="US" url="https://www.streetinsider.com/">streetinsider</source><ns1language>en</ns1language><category>Pneumonia</category><category>Measles</category><category>GastroentericSyndrome</category><category>Encephalitis</category><category>BloodProducts</category><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>RespiratorySyndrome</category><category>Cytomegalovirus</category><category>CoronavirusInfection</category><category>BloodProductsAdverseEffects</category><ns0entity id="2939849" name="Breast Cancer">Breast Cancer</ns0entity><ns0entity id="2102502" name="LinkedIn">LinkedIn</ns0entity><ns0entity id="988552" name="Facebook">Facebook</ns0entity><ns0entity id="2384931" name="Julie Cunningham">Julie Cunningham</ns0entity><ns0entity id="2252330" name="Merck &amp; Co">Merck &amp; Co</ns0entity><ns0entity id="2251432" name="Twitter Facebook">Twitter Facebook</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2589079" name="Access Program">Access Program</ns0entity><ns0entity id="2241552" name="Scot Ebbinghaus">Scot Ebbinghaus</ns0entity><ns0entity id="536410" name="YouTube">YouTube</ns0entity><ns0entity id="2254033" name="IIB">IIB</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="2361328" name="John Infanti">John Infanti</ns0entity><ns0entity id="3120154" name="Support Program">Support Program</ns0entity><ns0entity id="2013862" name="Nervous System">Nervous System</ns0entity><ns0entity id="2408413" name="Research Laboratories">Research Laboratories</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>40.60816 -74.27765</georss></item><item><title>GSK CEO Emma Walmsley On RSV Vaccines</title><link>https://www.valuewalk.com/gsk-ceo-emma-walmsley-on-rsv-vaccines/</link><ns0keywords>people,year,emma walmsley,diseases,cramer,walmsley on rsv,vaccine,rsv vaccines,great,innovation,industry,gsk ceo emma</ns0keywords><pubDate>Wed, 29 Mar 2023 21:13:00 +0200</pubDate><guid isPermaLink="false">valuewalk-d203e62ebd570f2c36a3e887fefb8744</guid><source country="US" url="https://www.valuewalk.com/feed/">valuewalk</source><ns1language>en</ns1language><category>PneumococcalInfection</category><category>AIDS-HIV</category><category>Communicabledisease</category><category>Influenza</category><category>Meningitis</category><category ns0trigger="shingles[3]; ">HerpesZoster</category><category>VZV</category><category>Antimicrobialresist</category><ns0entity id="2094664" name="Silicon Valley Bank">Silicon Valley Bank</ns0entity><ns0entity id="100120" name="Magic Johnson">Magic Johnson</ns0entity><ns0entity id="2003605" name="Emma Walmsley">Emma Walmsley</ns0entity><ns0entity id="2003605" name="Emma Walmsley">EMMA WALMSLEY</ns0entity><ns0entity id="2151307" name="radical">radical</ns0entity><ns0entity id="2528522" name="Coronavirus">Covid</ns0entity><ns0entity id="95342" name="Irish Republican Army">IRA</ns0entity><georss>39.90750 116.39723</georss></item><item><title>“Hemos introducido el concepto de calendario de por vida para dejar claro que la vacunación no acaba en la infancia”</title><link>https://www.notiulti.com/hemos-introducido-el-concepto-de-calendario-de-por-vida-para-dejar-claro-que-la-vacunacion-no-acaba-en-la-infancia/</link><ns0keywords>salud pública,galicia,gaceta médica continuamos,concepto de calendario,durán parrondo recoge,año,vida para dejar,vacunas,vacunación no acaba,líneas,introducido el concepto,vrs</ns0keywords><pubDate>Wed, 29 Mar 2023 20:11:00 +0200</pubDate><guid isPermaLink="false">notiulti-8a28ec3431b3a0f8d3cb56eb9979c9d2</guid><source country="ES" url="https://www.notiulti.com/feed/">notiulti</source><ns1language>es</ns1language><category>Herpes</category><category>Rotavirus</category><category>VZV</category><category>MedicinalXucts</category><category>Antimicrobialresist</category><category>HPV</category><category>Epidemic</category><category>CoronavirusInfection</category><category>Meningitis</category><category>Clinicaltrial</category><category ns0trigger="zoster[2]; herpes zoster[2]; ">HerpesZoster</category><ns0entity id="663698" name="Carmen Durán">Carmen Durán</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="3245917" name="Centro Gallego">Centro Gallego</ns0entity><ns0entity id="66108" name="Xunta de Galicia">Xunta de Galicia</ns0entity><georss>42.75508 -7.86621</georss></item><item><title>Sehstörungen bei Patienten nach COVID-19-Impfung, Ärzte warnen vor möglichen Risiken</title><link>https://uncutnews.ch/sehstoerungen-bei-patienten-nach-covid-19-impfung-aerzte-warnen-vor-moeglichen-risiken/</link><ns0keywords>impfung,abgeordnete mike belcher,symptome,sehstörungen bei patienten,risiken,patienten nach covid-19-impfung,auge,epoch times,ärzte warnen,impfstoffen,warnen vor möglichen,geimpften</ns0keywords><pubDate>Wed, 29 Mar 2023 17:23:00 +0200</pubDate><guid isPermaLink="false">uncut-news-5d68dcd4a9c680fa1201b1a2479fc163</guid><source country="CH" url="https://uncutnews.ch/feed/">uncut-news</source><ns1language>de</ns1language><category>Communicabledisease</category><category>Influenza</category><category>Epidemic</category><category>CoronavirusInfection</category><category ns0trigger="Gürtelrose[2]; ">HerpesZoster</category><ns0entity id="1024191" name="American Academy">American Academy</ns0entity><ns0entity id="2005352" name="Epoch Times">Epoch Times</ns0entity><ns0entity id="2252084" name="Centers for Disease Control">Centers for Disease Control</ns0entity><ns0entity id="678690" name="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</ns0entity><ns0entity id="2772416" name="Vaccine Adverse Event Reporting System">Vaccine Adverse Event Reporting System</ns0entity><ns0entity id="86269" name="Pfizer Inc">Pfizer</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="3100593" name="Mike Belcher">Mike Belcher</ns0entity><georss>34.00071 -81.03481</georss></item><item><title>InventHelp Inventor Develops New Roofing Accessory (SGM-212)</title><link>https://www.streetinsider.com/PRNewswire/InventHelp+Inventor+Develops+New+Roofing+Accessory+(SGM-212)/21434161.html</link><ns0keywords>inventhelp inventor develops,inventor from norman,ladder,roofing accessory sgm-212,develops new roofing,pittsburgh march 29,transporting shingles,inventhelp's invention submission,2023 /prnewswire/,ninth street,/prnewswire/ i thought</ns0keywords><pubDate>Wed, 29 Mar 2023 17:05:00 +0200</pubDate><guid isPermaLink="false">streetinsider-8166fc237cd976ec2064203b6e01089b</guid><source country="US" url="https://www.streetinsider.com/Press+Releases">streetinsider</source><ns1language>en</ns1language><category>VZV</category><category ns0trigger="shingles[3]; ">HerpesZoster</category><georss>35.22257 -97.43948</georss></item><item><title>InventHelp Inventor Develops New Roofing Accessory (SGM-212)</title><link>https://www.prnewswire.com/news-releases/inventhelp-inventor-develops-new-roofing-accessory-sgm-212-301781347.html</link><ns0keywords>inventhelp inventor develops,ladder,inventor from norman,roofing accessory sgm-212,develops new roofing,pittsburgh march 29,transporting shingles,inventhelp's invention submission,2023 /prnewswire/,ninth street,/prnewswire/ i thought</ns0keywords><pubDate>Wed, 29 Mar 2023 17:04:00 +0200</pubDate><guid isPermaLink="false">prnewswire-276e9c829248f941ab57374b7928d7a6</guid><source country="US" url="http://www.prnewswire.com/rss/usa/all-usa-news.rss">prnewswire</source><ns1language>en</ns1language><category>VZV</category><category ns0trigger="shingles[3]; ">HerpesZoster</category><georss>35.22257 -97.43948</georss></item><item><title>CLM adquiere más de 64.600 dosis de vacunas frente a herpes zóster</title><link>https://www.clm24.es/articulo/actualidad/gobierno-castilla-mancha-adquiere-mas-64600-dosis-vacunas-frente-herpes-zoster/20230329163822386125.html</link><ns0keywords>millones de euros,herpes zóster,castilla-la mancha,clm adquiere,vacunas frente,años,mancha ha aprobado,blanca fernández,seguros agrarios,gobierno de castilla-la,frente a herpes,ayudas,dosis de vacunas,equipos electromédicos,consejo de gobierno</ns0keywords><pubDate>Wed, 29 Mar 2023 16:49:00 +0200</pubDate><guid isPermaLink="false">clm24-71bb29d233c2f2ee4a0bef82ebfbf0ed</guid><source country="ES" url="https://www.clm24.es/rss/">clm24</source><ns1language>es</ns1language><category>Herpes</category><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><ns0entity id="2522546" name="Hospital General Universitario">Hospital General Universitario</ns0entity><ns0entity id="1461679" name="Blanca Fernandez">Blanca Fernández</ns0entity><ns0entity id="505243" name="Consejo de Gobierno">Consejo de Gobierno</ns0entity><georss>39.85810 -4.02263</georss></item><item><title>Varicella: Chickenpox and Shingles</title><link>https://www.healthvermont.gov/disease-control/other-diseases/varicella-chickenpox-and-shingles</link><ns0keywords>varicella,rash,people,vaccine,spread,person,blisters,chickenpox and shingles,varicella-zoster virus vzv,contagious disease caused,zoster</ns0keywords><pubDate>Wed, 29 Mar 2023 16:04:00 +0200</pubDate><guid isPermaLink="false">healthvermont-1122f2661ef6a4d5a03f06581cef106c</guid><source country="US" url="https://www.healthvermont.gov/media/newsroom/2020-news-releases">healthvermont</source><ns1language>en</ns1language><category>VZV</category><category>Encephalitis</category><category>RashSyndrome</category><category>Immunization</category><category ns0trigger="zoster[5]; herpes zoster[1]; shingles[8]; Shingles[2]; ">HerpesZoster</category><category>Herpes</category><category>Communicabledisease</category><category>ArtificialTissuesAdverseEffects</category><ns0entity id="3080519" name="Vermont Department">Vermont Department</ns0entity><georss>50.50301 13.63617</georss></item><item><title>Castilla-La Mancha adquirirá unas 65.000 dosis de vacunas contra el herpes zóster por ocho millones de euros</title><link>https://www.eldiario.es/castilla-la-mancha/social/castilla-mancha-adquirira-65-000-dosis-vacunas-herpes-zoster-ocho-millones-euros_1_10077882.html</link><ns0keywords>herpes zóster,castilla-la mancha adquirirá,dosis de vacunas,millones de euros,enfermedad,zoster europa press,años de edad,press el gobierno,gobierno de castilla-la,vacunación frente,blanca fernández,adquirirá unas 65.000,65.000 dosis,espera un aumento</ns0keywords><pubDate>Wed, 29 Mar 2023 14:55:00 +0200</pubDate><guid isPermaLink="false">eldiario-es-0d5e2fd4bf6b82957076e7a7b05858a4</guid><source country="ES" url="https://www.eldiario.es/blogs/">eldiario-es</source><ns1language>es</ns1language><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>HPV</category><category>Herpes</category><ns0entity id="26070" name="Europa Press">Europa Press</ns0entity><ns0entity id="1461679" name="Blanca Fernandez">Blanca Fernández</ns0entity></item><item><title>Vaccines, Vol. 11, Pages 760: Influenza, Pneumococcal and Herpes Zoster Vaccination Rates in Patients with Autoimmune Inflammatory Rheumatic Diseases</title><link>https://www.mdpi.com/2076-393X/11/4/760</link><ns0keywords>streptococcus pneumoniae,influenza,autoimmune inflammatory rheumatic,herpes zoster,vol,vaccines,vaccination rates,patients with autoimmune,inflammatory rheumatic diseases,aiird,pneumococcal,pages 760</ns0keywords><pubDate>Wed, 29 Mar 2023 14:51:00 +0200</pubDate><guid isPermaLink="false">mdpi-b4c6604e02d3db85bfb4a1c33ee70222</guid><source country="CH" url="https://www.mdpi.com/rss">mdpi</source><ns1language>en</ns1language><category ns0trigger="zoster[3]; herpes zoster[3]; Zoster[1]; Herpes Zoster[1]; ">HerpesZoster</category><category>VZV</category><category>CoronavirusInfection</category><category>Herpes</category><category>PneumococcalInfection</category><category>Influenza</category><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><georss>52.52437 13.41053</georss></item><item><title>BetterLife's Non-hallucinogenic LSD For Treating Mood Disorders Highlighted in Drug Discovery &amp; Development Article</title><link>https://investingnews.com/betterlife-s-non-hallucinogenic-lsd-for-treating-mood-disorders-highlighted-in-drug-discovery-development-article/</link><ns0keywords>patients receiving keytruda,occurred,adverse reactions,treatment of patients,lenvima,combination,common,single agent,grade,keytruda was discontinued,chemotherapy</ns0keywords><pubDate>Wed, 29 Mar 2023 14:49:00 +0200</pubDate><guid isPermaLink="false">investingnews-e729aec5447b025ae553919e36f6397a</guid><source country="CA" url="https://investingnews.com/category/daily/life-science-investing/feed/">investingnews</source><ns1language>en</ns1language><category>Encephalitis</category><category>BloodProducts</category><category>HaemorrhagicSyndrome</category><category>RespiratorySyndrome</category><category>Cytomegalovirus</category><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>Herpes</category><category>GastroentericSyndrome</category><category>Pneumonia</category><category>BloodProductsAdverseEffects</category><ns0entity id="2939849" name="Breast Cancer">Breast Cancer</ns0entity><ns0entity id="3027720" name="Moores Cancer Center">Moores Cancer Center</ns0entity><ns0entity id="251307" name="Eliav Barr">Eliav Barr</ns0entity><ns0entity id="70670" name="Annual Meeting">Annual Meeting</ns0entity><ns0entity id="3003426" name="University of California San Diego">University of California San Diego</ns0entity><ns0entity id="2254033" name="IIB">IIB</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="825531" name="Eisai Co">Eisai</ns0entity><ns0entity id="2013862" name="Nervous System">Nervous System</ns0entity><ns0entity id="2408413" name="Research Laboratories">Research Laboratories</ns0entity><ns0entity id="2250587" name="Cancer Institute">Cancer Institute</ns0entity><ns0entity id="2246399" name="Development Agreement">Development Agreement</ns0entity><ns0entity id="839570" name="New England Journal of Medicine">New England Journal of Medicine</ns0entity></item><item><title>Castilla-La Mancha adquirirá unas 65.000 dosis de vacunas contra el herpes zóster por ocho millones de euros</title><link>https://www.eldiario.es/castilla-la-mancha/social/castilla-mancha-adquirira-65-000-dosis-vacunas-herpes-zoster-ocho-millones-euros_1_10077882.html</link><ns0keywords>herpes zóster,castilla-la mancha adquirirá,dosis de vacunas,millones de euros,enfermedad,zoster europa press,años de edad,press el gobierno,gobierno de castilla-la,vacunación frente,blanca fernández,adquirirá unas 65.000,65.000 dosis,espera un aumento</ns0keywords><pubDate>Wed, 29 Mar 2023 14:41:00 +0200</pubDate><guid isPermaLink="false">ileon-0d5e2fd4bf6b82957076e7a7b05858a4</guid><source country="ES" url="https://ileon.eldiario.es/">ileon</source><ns1language>es</ns1language><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>HPV</category><category>Herpes</category><ns0entity id="26070" name="Europa Press">Europa Press</ns0entity><ns0entity id="1461679" name="Blanca Fernandez">Blanca Fernández</ns0entity></item><item><title>La Junta comprará 65.000 dosis de vacuna contra el herpes zóster para la población que cumple 65 y 80 años</title><link>https://www.lanzadigital.com/castilla-la-mancha/la-junta-comprara-65-000-dosis-de-vacuna-contra-el-herpes-zoster-para-la-poblacion-que-cumple-65-y-80-anos/</link><ns0keywords>población que cumple,dosis de vacuna,herpes zóster,castilla-la mancha,millones de euros,cumple 65,80 años,65 y 80,blanca fernández,junta comprará 65.000,gobierno regional,equipos electromédicos,comprará 65.000 dosis</ns0keywords><pubDate>Wed, 29 Mar 2023 13:37:00 +0200</pubDate><guid isPermaLink="false">lanzadigital-f79382b8a57030c7baee799974f1cec8</guid><source country="ES" url="https://www.lanzadigital.com/castilla-la-mancha/">lanzadigital</source><ns1language>es</ns1language><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>Herpes</category><ns0entity id="2522546" name="Hospital General Universitario">Hospital General Universitario</ns0entity><ns0entity id="1461679" name="Blanca Fernandez">Blanca Fernández</ns0entity><ns0entity id="505243" name="Consejo de Gobierno">Consejo de Gobierno</ns0entity><georss>39.85810 -4.02263</georss></item><item><title>Sanidad contratará 65.000 dosis de vacuna contra el herpes zóster para la población que cumple 65 y 80 años</title><link>https://www.europapress.es/castilla-lamancha/noticia-lm-contratara-65000-dosis-vacuna-contra-herpes-zoster-poblacion-cumple-65-80-anos-20230329124940.html</link><ns0keywords>población que cumple,dosis de vacuna,herpes zóster,castilla-la mancha,millones de euros,blanca fernández,cumple 65,80 años,65 y 80,sanidad contratará 65.000,equipos electromédicos,contratará 65.000 dosis,europa press</ns0keywords><pubDate>Wed, 29 Mar 2023 13:15:00 +0200</pubDate><guid isPermaLink="false">europapress-e0880c8191e36d28d8d8ab346d4c4fe1</guid><source country="ES" url="https://www.europapress.es/rss/rss.aspx?ch=282">europapress</source><ns1language>es</ns1language><category ns0trigger="zoster[1]; herpes zoster[1]; ">HerpesZoster</category><category>Herpes</category><ns0entity id="2522546" name="Hospital General Universitario">Hospital General Universitario</ns0entity><ns0entity id="26070" name="Europa Press">EUROPA PRESS</ns0entity><ns0entity id="1461679" name="Blanca Fernandez">Blanca Fernández</ns0entity><ns0entity id="505243" name="Consejo de Gobierno">Consejo de Gobierno</ns0entity></item></data>